Sue Washer | President/CEO

Sue Washer, President/CEO, AGTC

An experienced entrepreneur with a strong scientific and operational background, Sue brings a decade of experience in pharmaceutical management and research with Abbott Labs and Eli Lilly & Company and more than 16 years of senior management experience with entrepreneurial firms in Florida including three start-ups. At AGTC, Sue has successfully secured investments of more than $91 million from nationally recognized venture capitalists and granting agencies; negotiated and closed on a major collaboration with a top five Biotech company; lead the company to complete critical milestones; and recruited an experienced management team. Her experience as a group leader with Abbott’s Diagnostic Division helped hone her skills in bringing new products and technologies from the lab bench into the market place. Sue is the chair of Southeast BIO, is a member of the Executive Committee of BioFlorida and sits on the board of the Florida High Tech Corridor Council. She has a degree in biochemistry from Michigan State University and an MBA from the University of Florida where she was one of the first graduates from the Warrington College of Business Entrepreneurship program.


World Orphan Drug Congress USA 2018 - Conference Day Two @ 11:40

Pioneering partnerships between industry and patient groups to advance gene therapy research to treat inherited retinal diseases

  • Supporting research initiatives like My Retina Tracker registry and studies to identify barriers that prevent patients use of genetic testing
  • Leveraging partnerships and funding opportunities to increase gene therapy clinical trial enrollment
  • Working toward common objectives and maximizing patient groups’ and industry’s capabilities

back to speakers